Zealand Pharma A/s
(NASDAQ) ZEAL
This security has been delisted. This page is retained for historical reference.
ZEAL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowZEAL Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
76%
Net Income Margin
70%
Return on Equity
48%
Return on Capital
44%
Return on Assets
39%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$173.75M
Operating Income
$1.02B
EBITDA
$982.60M
Operating Cash Flow
$1.21B
Capital Expenditure
$22.13M
Free Cash Flow
$1.23B
Cash & ST Invst.
$1.43B
Total Debt
$787.43M
Zealand Pharma A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.08M
-76.2%
Gross Profit
$12.16M
-65.3%
Gross Margin
80.69%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
237
N/A
Net Income
$181.04M
+52.4%
EBITDA
$191.93M
+45.5%
Quarterly Fundamentals
Net Cash
$333.04M
-67.9%
Accounts Receivable
$92.58M
+629.3%
Inventory
$3.76M
-91.8%
Long Term Debt
$776.98M
+616.4%
Short Term Debt
$13.22M
+16.0%
Return on Assets
39.21%
N/A
Return on Invested Capital
44.06%
N/A
Free Cash Flow
$320.75M
-17.6%
Operating Cash Flow
$317.01M
-14.4%